heapsreal
iherb 10% discount code OPA989,
- Messages
- 10,212
- Location
- australia (brisbane)
Im pinching this from another ME/cfs site so hopefully know one minds but i thought was interesting.
August 10th, 2011 Alexandra Carmichael Posted in Infographics, Research Findings | 20 Comments
For the live-updated, interactive version of this infographic, click here.
The FDA has approved three drugs for Fibromyalgia, a condition of widespread pain and fatigue that affects 2-4% of the population. The three drugs are Lyrica, Cymbalta, and Savella. At CureTogether, 1,144 patients with Fibromyalgia came together to rate these drugs, among other treatments.
We were surprised to find that patients rate Lyrica, Cymbalta, and Savella as making their Fibromyalgia worse, not better (see the red part of the chart above.)
The treatments that help most, in the top right corner of the chart, are simple lifestyle changes: rest, heat, sleep, stress reduction.
While this is just one study, it suggests that the relative cost (financial and physical pain) of administering FDA-approved Fibromyalgia drugs compared to free, easy lifestyle changes should be considered when choosing a treatment for Fibromyalgia.
The rest of the results are in the graph above, which is divided into four squares
- Top right: the most popular and effective treatments (including Rest and Heat)
- Top left: effective treatments that not many people have tried, so they may be options to think about (including LDN and Hydrotherapy)
- Lower right: very popular but not very effective (including Lyrica and Cymbalta)
- Lower left: neither popular nor effective (including Savella and Effexor)
Where did this data come from? This is the result of a 3-year CureTogether study on Fibromyalgia. To thank everyone for participating, were publishing this study openly and freely.
This is part of our regular series of research findings. Of course, with each of these findings, there is a potential bias in patient self-selection and recall. Every research study has some bias, so we present these findings as just what they are patient-reported data to stimulate discussion and generate new insights for further research.
To see the chart heres a link http://www.mecfsforums.com/index.php/topic,9164.0.html
August 10th, 2011 Alexandra Carmichael Posted in Infographics, Research Findings | 20 Comments
For the live-updated, interactive version of this infographic, click here.
The FDA has approved three drugs for Fibromyalgia, a condition of widespread pain and fatigue that affects 2-4% of the population. The three drugs are Lyrica, Cymbalta, and Savella. At CureTogether, 1,144 patients with Fibromyalgia came together to rate these drugs, among other treatments.
We were surprised to find that patients rate Lyrica, Cymbalta, and Savella as making their Fibromyalgia worse, not better (see the red part of the chart above.)
The treatments that help most, in the top right corner of the chart, are simple lifestyle changes: rest, heat, sleep, stress reduction.
While this is just one study, it suggests that the relative cost (financial and physical pain) of administering FDA-approved Fibromyalgia drugs compared to free, easy lifestyle changes should be considered when choosing a treatment for Fibromyalgia.
The rest of the results are in the graph above, which is divided into four squares
- Top right: the most popular and effective treatments (including Rest and Heat)
- Top left: effective treatments that not many people have tried, so they may be options to think about (including LDN and Hydrotherapy)
- Lower right: very popular but not very effective (including Lyrica and Cymbalta)
- Lower left: neither popular nor effective (including Savella and Effexor)
Where did this data come from? This is the result of a 3-year CureTogether study on Fibromyalgia. To thank everyone for participating, were publishing this study openly and freely.
This is part of our regular series of research findings. Of course, with each of these findings, there is a potential bias in patient self-selection and recall. Every research study has some bias, so we present these findings as just what they are patient-reported data to stimulate discussion and generate new insights for further research.
To see the chart heres a link http://www.mecfsforums.com/index.php/topic,9164.0.html
